| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |